{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:52Z","timestamp":1761102232992,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004325","name":"Astra Zeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kock Foundations"},{"name":"The Faculty of Medicine Lund University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12955-016-0547-y","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T09:32:41Z","timestamp":1475573561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the external validity of algorithms to estimate EQ-5D-3L from the WOMAC"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-9099","authenticated-orcid":false,"given":"Aliasghar A.","family":"Kiadaliri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"issue":"6","key":"547_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(87)90019-1","volume":"40","author":"GW Torrance","year":"1987","unstructured":"Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593\u2013603.","journal-title":"J Chronic Dis"},{"issue":"2","key":"547_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","volume":"11","author":"JE Brazier","year":"2010","unstructured":"Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215\u201325.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"547_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00019053-200826090-00007","volume":"26","author":"J Brazier","year":"2008","unstructured":"Brazier J. Valuing health States for use in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):769\u201379.","journal-title":"Pharmacoeconomics"},{"key":"547_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-7-27","volume":"7","author":"D Rowen","year":"2009","unstructured":"Rowen D, Brazier J, Roberts J. Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes. 2009;7:27.","journal-title":"Health Qual Life Outcomes"},{"key":"547_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-7525-3-11","volume":"3","author":"AS Pickard","year":"2005","unstructured":"Pickard AS, Wang Z, Walton SM, Lee TA. Are decisions using cost-utility analyses robust to choice of SF-36\/SF-12 preference-based algorithm? Health Qual Life Outcomes. 2005;3:11.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"547_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","volume":"68","author":"TP Debray","year":"2015","unstructured":"Debray TP, Vergouwe Y, Koffijberg H, Nieboer D, Steyerberg EW, Moons KG. A new framework to enhance the interpretation of external validation studies of clinical prediction models. J Clin Epidemiol. 2015;68(3):279\u201389.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"547_CR7","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833\u201340.","journal-title":"J Rheumatol"},{"key":"547_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7525-6-51","volume":"6","author":"GR Barton","year":"2008","unstructured":"Barton GR, Sach TH, Jenkinson C, Avery AJ, Doherty M, Muir KR. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? Health Qual Life Outcomes. 2008;6:51.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"547_CR9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1524-4733.2010.00770.x","volume":"13","author":"F Xie","year":"2010","unstructured":"Xie F, Pullenayegum EM, Li SC, Hopkins R, Thumboo J, Lo NN. Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index. Value Health. 2010;13(8):873\u20138.","journal-title":"Value Health"},{"key":"547_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-12-37","volume":"12","author":"A Wailoo","year":"2014","unstructured":"Wailoo A, Hernandez Alava M, Escobar Martinez A. Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D. Health Qual Life Outcomes. 2014;12:37.","journal-title":"Health Qual Life Outcomes"},{"key":"547_CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4137\/CMAMD.S18356","volume":"7","author":"LE Miller","year":"2014","unstructured":"Miller LE, Block JE. An 8-week knee osteoarthritis treatment program of hyaluronic acid injection, Deliberate physical rehabilitation, and patient education is cost effective at 2 years follow-up: the osteoarthritis centers of America(SM) experience. Clin Med Insights Arthritis Musculoskelet Disord. 2014;7:49\u201355.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"547_CR12","doi-asserted-by":"crossref","first-page":"b2538","DOI":"10.1136\/bmj.b2538","volume":"339","author":"N Latimer","year":"2009","unstructured":"Latimer N, Lord J, Grant RL, O\u2019Mahony R, Dickson J, Conaghan PG, et al. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis. BMJ. 2009;339:b2538.","journal-title":"BMJ"},{"key":"547_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009742.2016.1181203","volume":"6","author":"AA Kiadaliri","year":"2016","unstructured":"Kiadaliri AA, Gerhardsson de Verdier M, Turkiewicz A, Lohmander LS, Englund M. Socioeconomic inequalities in knee pain, knee osteoarthritis, and health-related quality of life: a population-based cohort study in southern Sweden. Scand J Rheumatol. 2016;6:1\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"547_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039\u201349.","journal-title":"Arthritis Rheum"},{"issue":"Suppl A","key":"547_CR15","first-page":"3","volume":"3","author":"RD Altman","year":"1995","unstructured":"Altman RD, Hochberg M, Murphy Jr WA, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 1995;3(Suppl A):3\u201370.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"547_CR16","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/art.11088","volume":"48","author":"M Englund","year":"2003","unstructured":"Englund M, Roos EM, Lohmander LS. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum. 2003;48(8):2178\u201387.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"547_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372.","journal-title":"Health Policy"},{"issue":"11","key":"547_CR18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095\u2013108.","journal-title":"Med Care"},{"issue":"4","key":"547_CR19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341\u201353.","journal-title":"Health Econ"},{"issue":"3","key":"547_CR20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jval.2011.12.014","volume":"15","author":"M Hernandez Alava","year":"2012","unstructured":"Hernandez Alava M, Wailoo AJ, Ara R. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health. 2012;15(3):550\u201361.","journal-title":"Value Health"},{"issue":"7","key":"547_CR21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0272989X15577362","volume":"35","author":"M Coca Perraillon","year":"2015","unstructured":"Coca Perraillon M, Shih YC, Thisted RA. Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample: A Finite Mixture Approach. Med Decis Making. 2015;35(7):888\u2013901.","journal-title":"Med Decis Making"},{"issue":"9","key":"547_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18090","volume":"18","author":"L Longworth","year":"2014","unstructured":"Longworth L, Yang Y, Young T, Mulhern B, Hernandez Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess. 2014;18(9):1\u2013224.","journal-title":"Health Technol Assess"},{"key":"547_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1477-7525-8-141","volume":"8","author":"MM Versteegh","year":"2010","unstructured":"Versteegh MM, Rowen D, Brazier JE, Stolk EA. Mapping onto Eq-5 D for patients in poor health. Health Qual Life Outcomes. 2010;8:141.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"547_CR24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jval.2014.11.002","volume":"17","author":"B Pennington","year":"2014","unstructured":"Pennington B, Davis S. Mapping from the Health Assessment Questionnaire to the EQ-5D: the impact of different algorithms on cost-effectiveness results. Value Health. 2014;17(8):762\u201371.","journal-title":"Value Health"},{"key":"547_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-7525-8-21","volume":"8","author":"MJ Harrison","year":"2010","unstructured":"Harrison MJ, Lunt M, Verstappen SM, Watson KD, Bansback NJ, Symmons DP. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health Qual Life Outcomes. 2010;8:21.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"547_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jval.2012.10.010","volume":"16","author":"L Longworth","year":"2013","unstructured":"Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16(1):202\u201310.","journal-title":"Value Health"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-016-0547-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T10:47:30Z","timestamp":1526640450000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-016-0547-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1186\/s12955-016-0547-y","relation":{},"ISSN":["1477-7525"],"issn-type":[{"type":"electronic","value":"1477-7525"}],"subject":[],"published":{"date-parts":[[2016,10,4]]},"article-number":"141"}}